Session » Abstracts: Systemic Sclerosis & Related Disorders – Clinical III (2651–2656)
- 9:30AM-9:45AM
-
Abstract Number: 2651
Development and Validation of the Scleroderma Clinical Trials Consortium Classification Criteria for Systemic Sclerosis Heart Involvement
- 9:45AM-10:00AM
-
Abstract Number: 2652
Anti-mitochondrial antibodies in systemic sclerosis target enteric neurons and are associated with GI dysmotility
- 10:00AM-10:15AM
-
Abstract Number: 2653
First Prospective Evaluation of Recombinant Herpes Zoster Vaccine in Systemic Sclerosis: Immunogenicity, Safety, and Disease Activity Outcomes
- 10:15AM-10:30AM
-
Abstract Number: 2654
Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis
- 10:30AM-10:45AM
-
Abstract Number: 2655
Fetal and maternal outcomes in systemic sclerosis and very early diagnosis of systemic sclerosis pregnancies, a national prospective study
- 10:45AM-11:00AM
-
Abstract Number: 2656
Long-term effect of selexipag in systemic sclerosis-associated digital ulcers: a case control, multicentre, observational study